Test accuracy for Dengue Fever, Zika, and Chinkungunya diagnoses in Mexico is getting better by the day.
MONTERREY, Mexico, May 29th 2018 – Due to the public health’s impact of vector-borne diseases in Mexico, particularly Dengue Fever, Zika, and Chinkgunya, which represent more than 17% of global infectious diseases (WHO, 2017), the Epidemiologic Reference and Diagnostics Institute (InDRE for its acronym in spanish) performed a validation study for the new molecular biology test Viasure® RT-PCR Multiplex. This study confirmed the test’s high sensibility and specificity for detecting these diseases.
The Viasure® RT-PCR Multiplex test for Dengue Fever, Zika, and Chikungunya was designed in Spain by CertTest Biotec in 2016 and was introduced to Mexico in 2017 by Kabla Diagnosticos. Public Health Institutions, particularly the National Epidemiology Headquarters and the InDRE, were interested in adding arbovirus to their disease detection algorythm. We determined that the Viasure® test complies with InDRE’s strict guidelines (as a part of its epidemiology program), which serves as a national reference laboratory that provides testing and monitoring for a wide spectrum of agents and diseases through state Public Health Laboratories, and other Important laboratories that form an important part of the National Network for Epidemiologic Coordination. Ⓡ
The support provided by Viasure® to the National Network of Public Health Laboratories has proven to be a useful tool for epidemiological monitoring in Mexico. It is estimated that around 60% of Mexican territory has favorable conditions for the proliferation of these types of diseases (CENAPRECE, 2017). Furthermore, arbovirus detection through RT-PCR multiplex molecular techniques allow the user to determine the frequency of circulating viruses in vector mosquitoes.
According to the Panamerican Health Organization (2017), vector-borne diseases cause over 700,000 deaths annually. Thus there is an imminent risk of being exposed to them in our country’s endemic areas. Furthermore, people could be exposed to new types of arboviruses for which they have no immunity, coupled with other vector-borne diseases brought by mosquitoes that enter the country and proliferate.
Kabla is at the forefront of supplying diagnostics devices for timely and accurate detection of infectious diseases.